CIK 0001799191 · Accelerated filer<br>Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843562323
- Phone
- 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Warrant Nasdaq
- DFPH Common stock OTC
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure
- 4 Open-market sale 10% owner sold 2,851,061 shares at $3.99 ($11,375,733)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Planned sale Director sold 298,853 shares at $6.51 ($1,946,310)
- 8-K Event Material agreement · New debt or obligation
- 144 Insider Sale of Securities
- 4 Open-market buy 10% owner bought 12,000 shares at $6.54 ($78,480)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
- 4 Grant or award Director acquired 33,133 shares (grant or award)
- 4 Grant or award Director acquired 41,165 shares (grant or award)
- 4 Grant or award Director acquired 30,120 shares (grant or award)
- 4 Grant or award Director acquired 31,124 shares (grant or award)
- 4 Grant or award Director acquired 29,116 shares (grant or award)
- 4 Grant or award Director acquired 27,108 shares (grant or award)
- 4 Grant or award Director acquired 31,124 shares (grant or award)
Page 1 of 28 · 548 filings